Combining Immunotherapy With Oncogene-Targeted Therapy: A New Road for Melanoma Treatment

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2015.00046
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Combining Targeted Therapy With Immunotherapy inBRAF-Mutant Melanoma: Promise and Challenges

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Strong Emerging Rationale for Combining Oncogene-Targeted Agents With Immunotherapy

OncoImmunology
OncologyAllergyImmunology
2013English

Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Targeted Therapy and Immunotherapy: Emerging Biomarkers in Metastatic Melanoma

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2020English

Adoptive T-Cell Transfer Therapy and Oncogene-Targeted Therapy for Melanoma: The Search for Synergy

Clinical Cancer Research
Cancer ResearchOncology
2013English

Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma

Frontiers in Immunology
AllergyImmunology
2019English

Combining Immunotherapy With Radiation Therapy in Thoracic Oncology

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

Clinical Opportunities in Combining Immunotherapy With Radiation Therapy

Frontiers in Oncology
Cancer ResearchOncology
2012English

Mitochondria-Targeted Therapy for Metastatic Melanoma

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy